Inventor

NIE ZHE

US48 patents

⚠️ This page may combine multiple inventors who share the name “NIE ZHE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CELGENE QUANTICEL RES INC

26 patents

US9725441B2Aug 8, 2017

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC2 citations84

US11214542B2Jan 4, 2022

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC1 citations73

US10870634B2Dec 22, 2020

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC1 citations73

US10807956B2Oct 20, 2020

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC1 citations73

US10654830B2May 19, 2020

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC1 citations73

US10597365B2Mar 24, 2020

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC1 citations73

US10179769B2Jan 15, 2019

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC1 citations73

US11884648B2Jan 30, 2024

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC0 citations63

US10150754B2Dec 11, 2018

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC1 citations63

US9828343B2Nov 28, 2017

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC1 citations63

US9611221B2Apr 4, 2017

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC1 citations63

US10626103B2Apr 21, 2020

Inhibitor of lysine specific demethylase-1

CELGENE QUANTICEL RES INC0 citations52

US10626104B2Apr 21, 2020

Inhibitors of lysine specific demethylase-1

CELGENE QUANTICEL RES INC0 citations52

US10414750B2Sep 17, 2019

Inhibitors of lysine specific demethylase-1

CELGENE QUANTICEL RES INC0 citations52

US10273222B2Apr 30, 2019

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC0 citations52

US10174003B2Jan 8, 2019

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC0 citations52

US10173996B2Jan 8, 2019

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC0 citations52

US10100046B2Oct 16, 2018

Inhibitors of lysine specific demethylase-1

CELGENE QUANTICEL RES INC0 citations52

US10071984B2Sep 11, 2018

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC0 citations52

US9963441B2May 8, 2018

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC0 citations52

US9908865B2Mar 6, 2018

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC0 citations52

US9902719B2Feb 27, 2018

Inhibitors of lysine specific demethylase-1

CELGENE QUANTICEL RES INC1 citations52

US9896436B2Feb 20, 2018

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC1 citations52

US9714230B2Jul 25, 2017

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC0 citations52

US9701657B2Jul 11, 2017

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC0 citations52

US9604961B2Mar 28, 2017

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC0 citations52

QUANTICEL PHARMACEUTICALS INC

10 patents

US8952151B2Feb 10, 2015

Histone demethylase inhibitors

QUANTICEL PHARMACEUTICALS INC21 citations96

US9447045B2Sep 20, 2016

Histone demethylase inhibitors

QUANTICEL PHARMACEUTICALS INC20 citations93

US9085534B2Jul 21, 2015

Histone demethylase inhibitors

QUANTICEL PHARMACEUTICALS INC8 citations93

US8987461B2Mar 24, 2015

Histone demethylase inhibitors

QUANTICEL PHARMACEUTICALS INC13 citations91

US9676770B2Jun 13, 2017

Histone demethylase inhibitors

QUANTICEL PHARMACEUTICALS INC5 citations84

US9133166B2Sep 15, 2015

Histone demethylase inhibitors

QUANTICEL PHARMACEUTICALS INC10 citations84

US9107916B2Aug 18, 2015

Histone demethylase inhibitors

QUANTICEL PHARMACEUTICALS INC4 citations84

US11639333B2May 2, 2023

Histone demethylase inhibitors

QUANTICEL PHARMACEUTICALS INC0 citations63

US9527829B2Dec 27, 2016

Histone demethylase inhibitors

QUANTICEL PHARMACEUTICALS INC2 citations63

US9458129B2Oct 4, 2016

Histone demethylase inhibitors

QUANTICEL PHARMACEUTICALS INC1 citations63

ANNAPURNA BIO INC

3 patents

US11944622B2Apr 2, 2024

Compounds and compositions for treating conditions associated with APJ receptor activity

ANNAPURNA BIO INC0 citations56

US11471455B2Oct 18, 2022

Compounds and compositions for treating conditions associated with APJ receptor activity

ANNAPURNA BIO INC1 citations56

US11724997B2Aug 15, 2023

Compounds and compositions for treating conditions associated with APJ receptor activity

ANNAPURNA BIO INC0 citations46

ARIKAWA YASUYOSHI

2 patents

US8440689B2May 14, 2013

Fused heteroaromatic pyrrolidinones

ARIKAWA YASUYOSHI23 citations90

US9181255B2Nov 10, 2015

Fused heteroaromatic pyrrolidinones as SYK inhibitors

ARIKAWA YASUYOSHI2 citations60

CAO SHELDON X

1 patent

US8318727B2Nov 27, 2012

Polo-like kinase inhibitors

CAO SHELDON X13 citations77

TAKEDA PHARMACEUTICAL

1 patent

US9108970B2Aug 18, 2015

Fused heteroaromatic pyrrolidinones

TAKEDA PHARMACEUTICAL2 citations62

ACONCAGUA BIO INC

1 patent

US12486269B2Dec 2, 2025

Compounds and compositions for treating conditions associated with calcitonin receptor and/or amylin receptor activity

ACONCAGUA BIO INC0 citations53

POLARIS GROUP

1 patent

US7517882B2Apr 14, 2009

Protein kinase inhibitors

POLARIS GROUP3 citations52

TAKEDA PHARMACEUTICALS CO

1 patent

US9663514B2May 30, 2017

Substituted 6-aza-isoindolin-1-one derivatives

TAKEDA PHARMACEUTICALS CO0 citations51

MCBRIDE CHRISTOPHER

1 patent

US8202990B2Jun 19, 2012

Polo-like kinase inhibitors

MCBRIDE CHRISTOPHER0 citations46

KONO MITSUNORI

1 patent

US9056873B2Jun 16, 2015

Substituted 6-aza-isoindolin-1-one derivatives

KONO MITSUNORI0 citations45